Prof. Dr. med. Daniela S. Krause Beruflicher Werdegang 10/1992 – 1 2/1998: Medical School, Free University Berlin 12/1998: Doctoral thesis (Dr. med.), Medical Faculty of the University of the Saarland, Germany, Advisor: Professor Peter Hertel 01/1999 – 08/2000: Internship and Residency, Dept. of Internal Medicine (Haematology/Oncology), Director: Professor Dieter Huhn 09/2000 – 04/2001: Postdoctoral fellowship in the group of Prof. Elliott Kieff, Channing Laboratory, Harvard University, Boston, USA 05/2001 – 06/2005: Postdoctoral fellowship in the group of Prof. Richard Van Etten, The CBR Institute for Biomedical Research, Harvard Medical School, Boston, USA (for last 8 months at Tufts University) 07/2005 – 06/2008: Residency and Chief Residency in Clinical Pathology, Department of Pathology, Massachusetts General Hospital, Harvard University, Boston, MA 07/2008 – 06/2009: Fellowship in Transfusion Medicine, Harvard University, Boston, MA 07/2009 – 06/2010: T32 Training Grant (National Cancer Institute), Massachusetts General Hospital, Harvard University, Boston, MA, Advisor: Professor David Scadden 07/2010 – 06/2014: K08 Mentored Clinical Scientist Award (National Cancer Institute), Massachusetts General Hospital, Harvard University, Boston, MA, Advisor: Professor David Scadden and Graduate Assistant in Pathology at Massachusetts General Hospital, and staff at Beth Israel Deaconess Medical Center, both Harvard University, Boston, MA Seit 04/2012: Junior Faculty Member and Instructor, Harvard University, Boston, MA Seit 07/2014: Research Group leader, Georg-Speyer-Haus, Frankfurt am Main Seit 09/2015: ‘Berufung’ to a W2 professorship at the Centre for Cell and Gene Therapy (CGT) in Frankfurt am Main Auszeichnungen und Preise 05/2006: 04/2006: 05/2008: 07/2009: 07/2010: 05/2012: 04/2014: 04/2014: Award for contributions to cancer research and fine musicianship, Longwood Symphony Orchestra, Harvard University Vickery Grant, Department of Pathology, Massachusetts General Hospital, Harvard University 3rd prize, Clinical Research Day, Massachusetts General Hospital, Harvard University T32 Training grant, National Cancer Institute, USA KO8 Mentored Clinical Scientist Development Award, National Cancer Institute, USA Poster of Merit Award for Outstanding Poster, Office of Research Career Development, Massachusetts General Hospital, Harvard University 2013 Partners in Excellence Team Award (Special Coagulation Laboratory), Partners Healthcare, Harvard University 2013 Partners in Excellence Team Award (Transfusion Medicine), Partners Healthcare, Harvard University Forschungsprojekte Traditionally, treatment of the leukaemais has targeted the leukaemia cells themselves. However, several groups, including ours, have shown that pharmacological modification of the bone marrow microenvironment, which „houses“ the leukaemia, can lead to eradication of leukaemic stem cells. By the use of various leukaemia models and pharmacological agents our laboratory focuses on inhibiting different pathways of communication between leukaemia cells and the bone marrow niche in order to improve current therapies. Publikationen
© Copyright 2025 ExpyDoc
